GMP compliance – Page 5

How to Build a CAPA Roadmap After FDA Inspection Findings

Creating an Effective CAPA Roadmap Following FDA Inspection Findings Facing findings from an FDA inspection can be a significant challenge for any pharmaceutical manufacturer. The ability to construct a reliable…

Post-Inspection Remediation Plan for Pharma GMP Findings

Developing an Effective Remediation Plan Following Pharma GMP Findings The pharmaceutical industry continuously faces stringent regulatory inspection processes aimed at ensuring compliance with Good Manufacturing Practices (GMP). Following an inspection,…

Ongoing Stability CAPA Examples for Missed Time Points

Addressing Ongoing Gaps in Stability Programs for Missed Time Points In the pharmaceutical manufacturing industry, maintaining the integrity of stability studies is crucial for regulatory compliance and effective shelf-life management.…

ICH Q1D Bracketing and Matrixing Checklist for Inspection Readiness

Addressing Issues Related to ICH Q1D Bracketing and Matrixing Misuse The misuse of bracketing and matrixing in stability studies can lead to significant regulatory concerns, resulting in failed audits and…

Ongoing Stability Case Study: From Missed Pulls to Sustainable CAPA

Addressing Gaps in Ongoing Stability Programs: A Practical Case Study Approach In the pharmaceutical industry, maintaining the integrity of products through effective stability programs is paramount. However, many organizations encounter…

Bracketing and Matrixing SOP Requirements for GMP Stability Programs

Understanding and Addressing Bracketing and Matrixing Misuse in GMP Stability Programs In the realm of pharmaceutical manufacturing, ensuring product stability throughout its shelf life is paramount. However, the misuse of…

How to Build a Dashboard for Ongoing Stability Program Compliance

Strategies to Establish an Effective Dashboard for Ensuring Compliance in Ongoing Stability Programs In the pharmaceutical manufacturing landscape, maintaining compliance with ongoing stability programs is critical to ensuring product quality…

Why Bracketing and Matrixing Need Management Approval and QC Alignment

Managing Bracketing and Matrixing in Pharmaceutical Stability Studies In the complex landscape of pharmaceutical stability studies, the mismanagement of bracketing and matrixing strategies can lead to significant compliance issues and…

Ongoing Stability Program Gaps in Outsourced QC Laboratories

Addressing Gaps in Ongoing Stability Programs for Outsourced QC Labs In the pharmaceutical industry, stability programs serve as a foundational element ensuring product quality over time. However, when these programs…

How to Combine Bracketing with Ongoing Stability Commitments

Understanding and Resolving Bracketing and Matrixing Misuse in Stability Studies In pharmaceutical stability studies, the effective application of bracketing and matrixing designs is crucial for ensuring product integrity over time…

How to Correct Ongoing Stability Sample Labeling and Mix-Up Risks

Addressing Risks of Labeling and Mix-Ups in Stability Samples In the highly regulated environment of pharmaceutical manufacturing, ongoing stability program gaps can lead to significant risks, particularly in the management…

Matrixing Misuse Due to Poor Batch Selection Strategy

Addressing Bracketing and Matrixing Misuse in Stability Studies In the pharmaceutical industry, the effective management of stability studies is critical, particularly when utilizing bracketing and matrixing strategies. An increasing number…